Skip to main content Accessibility help
×
Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-01-08T05:15:52.471Z Has data issue: false hasContentIssue false

Chapter 27 - Other Substance Use Disorders

Published online by Cambridge University Press:  02 January 2025

Marsal Sanches
Affiliation:
McGovern Medical School, Texas
Jair C. Soares
Affiliation:
McGovern Medical School, Texas
Get access

Summary

Substance use disorders (SUD) present significant public health challenges. The management of SUD is complex and involves a range of approaches, including psychotherapy, motivational interviewing, medications, psychosocial interventions, and peer recovery. This chapter provides an overall review of the main aspects involved in the diagnosis and management of SUDs.

Type
Chapter
Information
Fundamentals of Clinical Psychiatry
A Practical Handbook
, pp. 269 - 280
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the United States: results from the 2021 National Survey on Drug Use and Health. 2021. Available at: www.samhsa.gov/data/sites/default/files/reports/rpt39443/2021NSDUHFFRRev010323.pdf (accessed June 24, 2024).Google Scholar
National Institute for Drug Abuse. Overdose death rates. 2021. www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates (accessed June 28, 2021).Google Scholar
Smith, PC, Schmidt, SM, Allensworth-Davies, D, Saitz, R. A single-question screening test for drug use in primary care. Arch Intern Med 2010; 170: 11551160.CrossRefGoogle ScholarPubMed
American Psychiatric Association, ed. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. American Psychiatric Association; 2013.Google Scholar
Donroe, JH, Holt, SR, O’Connor, PG, Sukumar, N, Tetrault, JM. Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice. Drug Alcohol Depend 2017; 180: 4651.CrossRefGoogle ScholarPubMed
Accurso, AJ, Lee, JD, McNeely, J. High prevalence of urine tampering in an office-based opioid treatment practice detected by evaluating the norbuprenorphine to buprenorphine ratio. J Subst Abuse Treat 2017; 83: 6267.CrossRefGoogle Scholar
Holt, SR, Donroe, JH, Cavallo, DA, Tetrault, JM. Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: case examples in opioid use disorder. Drug Alcohol Depend 2018; 186: 171174.CrossRefGoogle ScholarPubMed
Volkow, ND, Fowler, JS, Wang, G-J. The addicted human brain: insights from imaging studies. J Clin Invest 2003; 111: 14441451.CrossRefGoogle ScholarPubMed
Miller, SC, Fiellin, DA, Rosenthal, RN, Saitz, R, American Society of Addiction Medicine, eds. The ASAM Principles of Addiction Medicine. 6th edition. Wolters Kluwer; 2019.Google Scholar
ASAM Criteria Intake Assessment Guide. Default. www.asam.org/asam-criteria/criteria-intake-assessment-form (accessed December 4, 2022).Google Scholar
Miller, WR, Rollnick, S. Motivational Interviewing: Helping People Change. 3rd ed. Guilford Press; 2013.Google Scholar
Buckner, JD, Ecker, AH, Beighley, JS, Zvolensky, MJ, Schmidt, NB, Shah, SM et al. Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders. Clin Case Stud 2016; 15: 6883.CrossRefGoogle ScholarPubMed
Barry, DT, Beitel, M, Cutter, CJ, Fiellin, DA, Kerns, RD, Moore, BA et al. An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain. Drug Alcohol Depend 2019; 194: 460467.CrossRefGoogle ScholarPubMed
Hand, DJ, Ellis, JD, Carr, MM, Abatemarco, DJ, Ledgerwood, DM. Contingency management interventions for tobacco and other substance use disorders in pregnancy. Psychol Addict Behav J Soc Psychol Addict Behav 2017; 31: 907921.CrossRefGoogle ScholarPubMed
Stancliff, S, Phillips, BW, Maghsoudi, N, Joseph, H. Harm reduction: front line public health. J Addict Dis 2015; 34: 206219.CrossRefGoogle ScholarPubMed
Gonzales, D, Rennard, SI, Nides, M, Oncken, C, Azoulay, S, Billing, CB et al. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 2006; 296: 4755.CrossRefGoogle ScholarPubMed
Schnoll, R, Leone, F, Veluz-Wilkins, A, Miele, A, Hole, A, Jao, NC et al. A randomized controlled trial of 24-weeks of varenicline for tobacco use among cancer patients: efficacy, safety, and adherence. Psychooncology 2019; 28: 561569.CrossRefGoogle ScholarPubMed
Anthenelli, RM, Benowitz, NL, West, R, Aubin, LS, McRae, T, Lawrence, D et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. The Lancet 2016; 387: 25072520.CrossRefGoogle Scholar
Abuse NI on D. How effective are medications to treat opioid use disorder? Natl. Inst. Drug Abuse. www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/efficacy-medications-opioid-use-disorder (accessed June 30, 2021).Google Scholar
Tanum, L, Solli, KK, Latif, Z-H, Benth, , Opheim, A, Sharma-Haase, K et al. Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: a randomized clinical noninferiority trial. JAMA Psychiatry 2017; 74: 11971205.CrossRefGoogle ScholarPubMed
Bizzarri, JV, Sbrana, A, Rucci, P, Ravani, L, Massei, GJ, Gonnelli, C et al. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity. Bipolar Disord 2007; 9: 213220.CrossRefGoogle ScholarPubMed
Callaghan, RC, Veldhuizen, S, Jeysingh, T, Orlan, C, Graham, C, Kakouris, G et al. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J Psychiatr Res 2014; 48: 102110.CrossRefGoogle ScholarPubMed
Moeller, KE, Kissack, JC, Atayee, RS, Lee, KC. Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens. Mayo Clin Proc 2017; 92: 774796.CrossRefGoogle ScholarPubMed
Levy, S, Weitzman, ER, Marin, AC, Magane, KM, Wisk, LE, Shrier, LA. Sensitivity and specificity of S2BI for identifying alcohol and cannabis use disorders among adolescents presenting for primary care. Subst Abuse 2021; 42: 388395.CrossRefGoogle ScholarPubMed
Nielsen, S, Gowing, L, Sabioni, P, Le Foll, B. Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev 2019; 2019: CD008940.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×